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ABSTRACT
Objective: The main objective of the present investigation was to develop a simple isocratic stability indicating reversed phase liquid chromatographic 
method and validate the proposed method and to apply it for the estimation of ketorolac tromethamine, a non-steroidal anti-inflammatory drug in 
pure and pharmaceutical formulations. 
Methods: Waters high performance liquid chromatographic 2695 series system, inertsil ODS, C18 (150 mm × 4.6 mm × 5.0 µ) column and UV-visible 
detector with photo diode array detection was adopted for the method development. The components were separated by injecting about 20 µL 
working standard solution of concentration 5 µg/mL, using mobile phase prepared by mixing buffer of 100 mM potassium dihydrogen orthophosphate 
solution of pH 4.5 and acetonitrile in the ratio 60:40 v/v at a flow rate of 0.8 mL/minute, and the components were detected at a wavelength of 316 nm. 
Results: The proposed method was validated as per ICH guidelines. The developed method was found to be precise, accurate, linear, robust and 
rugged. A study of forced degradation was carried out and found that the drug was stable under variety of degradation conditions. 
Conclusion: The proposed method was adopted for assay of pharmaceutical formulations and recommended for routine analysis in any quality 
control laboratory.
Keywords: Ketorolac tromethamine, Validation, Assay, Forced degradation, Pharmaceutical formulations.
INTRODUCTION
Ketorolac tromethamine (KTR) is a member of the pyrrolo-pyrrole 
group of non-steroidal anti-inflammatory drugs (NSAIDs) which acts 
by inhibiting the bodily synthesis of prostaglandins. An ophthalmic 
solution of KTR is available and is used to treat eye pain and to 
relieve the itchiness and burning of seasonal allergies. KTR in its 
oral (tablet or capsule) and intramuscular (injected) preparations 
is a racemic mixture of both (S)-(−)-ketorolac, the active isomer, and 
(R)-(+)-ketorolac. The chemical name for KTR is (±)-5-benzoyl-2,3-
dihydro-1 H-pyrrolizine-1-carboxylic acid, compound with 2-amino-
2-(hydroxymethyl)-1,3-propanediol (1:1). The molecular formula and 
molecular weight of the selected drug are C15H13O3 C4H11NO3 (C19H24N2O6) 
and 376.41 g per mole respectively. KTR may exist in three crystal forms 
soluble in water and is available as toradol, acular and sprix. Toradol 
is available as round, white, film-coated, red-printed tablets. Each 
tablet contains 10 mg KTR, the active ingredient, with added lactose, 
magnesium stearate and microcrystalline cellulose. The white film-
coating contains hydroxypropyl methylcellulose, polyethylene glycol 
and titanium dioxide. Its chemical structure of KTR is given in Fig. 1.
An extensive literature survey was carried out and found a few high 
performance liquid chromatographic (HPLC) methods for the determination 
of KTR in different biological fluids [1-5] and formulations [6-9] were 
reported for the impurity profile study of KTR. Stability indicating and 
simultaneous determination methods [10-12] in human plasma and 
formulations were also reported. One HPTLC method [13] and an automatic 
fluorescence method [14] were also developed for the determination of 
KTR. The main objective of the proposed method is to develop a novel, rapid 
and economic liquid chromatographic procedure for the determination of 
KTR in pure and formulations, and also to study the stability of the drug 
under the forced degradation studies. Based on the nature of the drug and 
available chromatographic procedures the authors made some trails to 
reduce the retention time and run time of the analysis by changing polarity 
of the mobile phase, choosing chromatographic column having long carbon 
chain length in the column material and flow rate of the mobile phase, and 
succeeded in their attempts.
METHODS
Instrumentation
Waters HPLC 2695 series consisting 4 pumps, auto sampler, having 
capacity of volume of injection 5-500 µL, with 5 racks and each has 24 
vials holding capacity with temperature control, UV-visible detector 
with photo diode array detection equipment was used in the present 
investigation. Thermostat column compartment connected it has a 
capacity to maintain 5-60°C column temperature. Empower software-2 
software was used for acquisition of chromatographic data.
Chemicals and reagents
Analytical grade potassium dihydrogen orthophosphate, ortho 
phosphoric acid hydrochloric acid, sodium hydroxide and hydrogen 
peroxide were purchased from Qualigens Fine Chemicals Ltd., Mumbai. 
Acetonitrile of HPLC grade is obtained from E. Merck. (India) Ltd., 
Mumbai. Kerorolac tromethamine is gifted by Hetro Drugs Limited, 
Hyderabad. The commercially available KTR tablets were purchased 
from the local pharmacy.
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Fig. 1: Chemical structure of Ketorolac tromethamine
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Buffer preparation: Prepared 100 mM potassium dihydrogen 
orthophosphate solution, and its pH was adjusted to 4.5 with dilute 
orthophosphoric acid solution.
Mobile phase preparation: Mobile phase was prepared by mixing buffer 
and acetonitrile at 60:40 ratio and sonicated the resulting solution and 
degassed it using vacuum filtration through 0.4 µ membrane filter.
Preparation of standard solution: Weighed and transferred 50 mg of 
KTR working standard into 100 mL volumetric flask, added 50 mL of 
diluent and sonicated to dissolve and finally diluted to volume with 
diluent. Then about 1.0 mL of above solution was transferred into 
100 mL volumetric flask and diluted to volume with diluent.
Preparation of sample solution: An amount of fine powder of Toradol 
equivalent to 50 mg was weighed and transferred into a cleaned 
100 mL volumetric flask and dissolved in 50 mL of diluent, sonicated 
for 10 minutes and diluted up to the mark. Further filtered the solution 
through 0.4 µ membrane filter and then 1.0 mL of the solution was 
diluted to 100 mL to obtain the final concentration of 5 µg/mL.
Chromatographic method development
To optimize the HPLC method, one of the chromatographic conditions 
such as column, mobile phase, injection volume, flow rates, column 
temperature and detection wavelength was varied keeping other 
constant, chromatograms were recorded for each variation, and 
chromatographic parameters such as retention time, number of 
theoretical plates, tailing factor, area of the peak and peak height were 
obtained. Finally, the following procedure was found to be optimized 
chromatographic procedure.
About 20 µL of blank solution or placebo solution or standard solution 
was injected into an Inertsil ODS, C18 (150 mm × 4.6 mm × 5.0 µ) 
column maintained at a temperature of 30°C. The component were 
separated by using mobile phase of buffer and acetonitrile in the 
ratio 60:40 (v/v) at a flow rate 0.8 mL/minute under an isocratic mode, 
and the components were detected at a wavelength 316 nm using 
photodiode array (PDA) detector.
Method validation
The developed method was validated to demonstrate the proposed 
method is scientifically sound and that it serves the intended analytical 
purpose. Validation of the assay procedure was carried out using the 
following parameters.
Specificity
To find out the specificity of the proposed method, about 20 µL of blank or 
working standard or sample solution was injected into the HPLC system, 
and chromatograms were recorded under the optimized chromatographic 
conditions. In blank chromatogram, no peaks were found where as in 
standard and sample chromatograms a sharp symmetrical peak with 
tailing <2.0 and plate count more than 2000 was found.
Precision
System precision: To find the system precision, about 20 µL of working 
standard solution of concentration 5 µg/mL was injected into the HPLC 
system 6 times, chromatograms were recorded under the optimized 
chromatographic conditions, and the chromatographic parameters such 
as retention time, peak area, peak height, tailing factor and number of 
theoretical plates were obtained.
Method precision: To obtain method precision, a standard solution of 
concentration 5 μg/ml was prepared 6 times and chromatographic 
parameters were obtained under the normal conditions.
Linearity
In the present investigation, a study of linearity was established 
by preparing a series of six standard solutions over the range of 
concentration 1.25-7.50 µg/mL from standard stock solution, and 
chromatograms were obtained under the optimized conditions by 
injecting each of the solution twice into the system and chromatographic 
parameters were evaluated.
Sensitivity
The sensitivity is expressed in terms of limit of detection (LOD) 
and limit of quantitation (LOQ). The LOD of an individual analytical 
procedure is the lowest concentration of analyte in a sample which can 
be detected but not necessarily quantitated as an exact value. The LOQ 
is a parameter of the quantitative assay for low levels of compounds 
in sample matrices and is used particularly for the determination of 
impurities and/or degradation products. The values of LOD and LOQ 
were calculated from the slope and standard deviation of the intercept.
Accuracy
In the proposed method accuracy was evaluated by using standard 
addition method, in which three concentration levels (80%, 100% and 
120% with respect to precision concentration) were prepared by adding 
different amounts of standard to a constant amount of pre analyzed 
sample, and each solution was injected into column in triplicate, 
chromatograms were recorded and chromatographic parameters were 
evaluated. The percent of recovery was calculated by from mean peak 
area of standard and spike level.
Ruggedness
The ruggedness of an analytical method is the degree of reproducibility 
of test results obtained by the analysis of the same samples under a 
variety of conditions. In the proposed method, the study of ruggedness 
was carried out by preparing working standard solutions of 5.0 μg/ml 
and analyzed in 2 different days.
Intraday precision: Working standard solution of concentration 
5 µg/mL was prepared 6 times from the standard stock solution on 
the same day (day-1), about 20 µL of these solutions was injected into 
the column and the chromatograms were obtained under the same 
optimized conditions, and the relative standard deviation (%RSD) was 
calculated on area of the six peaks and found to be <2.0.
Inter day precision: About 5 µg/mL working standard solution was 
prepared 6 times from the standard stock solution on day-2, and 
about 20 µL of these solutions was injected into the column and the 
chromatograms were obtained under the same optimized conditions, 
and the %RSD was calculated on area of the six peaks and found to be 
<2.0.
Robustness
The robustness of the proposed method was demonstrated by carrying 
out intentional method variations like mobile phase flow changes and 
column oven temperature variations. In the present investigation, 
working standard solution of concentration 5 µg/ml was prepared, 
and chromatogram was obtained for deliberate variations in method 
parameters like flow rate and temperature.
Degradation Studies
Acid hydrolysis
Transferred quantitatively 100 mg of ketorolac API in to 200 mL RB 
flask, added 100 mL of freshly prepared 0.1 N HCl and left for 12 hrs. 
After that filtered the solution through filter paper and neutralized the 
solution with 0.1 N NaOH, then about 0.5 mL of filtrate was diluted to 
100 mL with mobile phase.
Base hydrolysis
About 100 mg of ketorolac API was accurately weighed and transferred 
into a 200 mL RB flask and dissolved in 100 mL of freshly prepared 
0.1 N NaOH, and left the solution for 12 hrs. After 12 hrs, the solution 
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was filtered and neutralized the solution with 0.1 N HCl, then about 
0.5 mL of filtrate was diluted to 100 mL with mobile phase.
Oxidation
An amount of 100 mg of ketorolac was added to 100 ml of freshly 
prepared 1.0% hydrogen peroxide taken in a 200 mL RB flask and 
allowed to react it for 12 hrs and then 0.5 ml of above filtered solution 
was to 100 ml with mobile phase.
Heat exposure
Transferred quantitatively 100 mg of ketorolac API on to clean and dry 
petri dish, spread it throughout the plate and placed the petri dish in an 
oven, which is maintaining at 100°C for 12 hrs. After 12 hrs, transferred 
the contents into 100 mL volumetric flask and added 100 mL of 
diluents, sonicated it for 10 minutes and dilute volume with diluent. 
Further filtered the solution and about 0.5 ml of this filtrate was diluted 
to 100 ml with mobile phase.
UV exposure
About 100 mg of ketorolac was taken on to clean and dry petri dish, 
placed in UV Chamber for 12 hrs. After 12 hrs transferred the contents 
into 100 mL volumetric flask added 100 mL of diluent and sonicated it 
for 10 minutes and diluted to volume with diluent. Further filtered the 
solution through filter paper and 0.5 mL of the solution was diluted to 
100 mL with mobile phase.
RESULTS AND DISCUSSION
System suitability
About 20 µL of standard solution of concentration 5 µg/mL was 
injected into an Inertsil ODS, C18 (150 mm × 4.6 mm × 5.0 µ) column 
and the separation was achieved by using mobile phase of buffer and 
acetonitrile in the ratio 60:40 (v/v) at a flow rate 0.8 mL/minute under 
an isocratic mode, and the components were detected at a wavelength 
316 nm using PDA detector. The system suitable parameters were given 
in Table 1.
Specificity
Specificity of the proposed method was determined by injecting about 
20 µL of blank or working standard or sample solution into the HPLC 
system and chromatograms (Figs. 2 and 3) were recorded under 
the optimized chromatographic conditions. The chromatograms of 
standard and sample showed that only one peak with 100% peak area 
at retention time 2.927 and 2.922 minutes respectively.
Precision
Precision, repeatability of a method was expressed as a percent of 
%RSD of finite replicate measurements. In the present investigation, 
the system precision was evaluated by injecting about 20 µL of working 
standard solution into the HPLC system 6 times, chromatograms 
were recorded under the optimized chromatographic conditions 
and %RSD was evaluated on retention time and peak area, and 
found to be within the acceptable limits. Method precision was 
determined for six chromatograms of six working standard solutions 
of concentration 5 µg/mL, the %RSD was determined on retention time 
and peak area of six chromatograms and found to be <2.0. The results 
of precision were presented in Table 2.
Linearity
Linearity, a study of dependence of instrument response on 
concentration of the analyte was determined by getting chromatograms 
twice and their peak area of a series of six standard solutions of 
concentration from 1.25 µg/mL to 7.50 µg/mL. A calibration curve 
(Fig. 4) was plotted peak area as a function of concentration of the drug 
Table 2: Results of precision studies






RT Area RT Area
1 2.924 3305808 1 2.921 3285212
2 2.927 3265045 2 2.922 3265244
3 2.923 3282897 3 2.921 3285612
4 2.928 3282585 4 2.925 3281866
5 2.926 3265864 5 2.926 3284688
6 2.931 3283162 6 2.928 3285275
Mean 2.927 3280894 Mean 2.924 3281316.167
SD 0.0029 14898.4 SD 0.0029 7991.122
RSD 0.098 0.454 RSD 0.100 0.244
RT: Reverse transcription, %RSD: Relative standard deviation, SD: Standard 
deviation
Table 1: System suitable parameters
Serial no RT Area Height % area Tailing Plate count
Standard 2.927 3265045 310226 100.00 1.13 3795
Sample 2.922 3267545 318116 100.00 1.15 3805
Blank
RT: Reverse transcription
Fig. 2: Reversed phase-high performance liquid chromatographic 
chromatogram of ketorolac standard
Fig. 3: Reversed phase-high performance liquid chromatographic 
chromatogram of ketorolac sample
Fig. 4: Calibration plot drawn mean peak area against 
concentration of the drug
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and found to be linear with positive slope. The slope, intercept and 
correlation coefficient were determined and presented in Table 3.
Sensitivity
The sensitivity of the proposed method was presented in terms of LOD 
and LOQ and these were calculated from standard deviation of response 
and slope of the calibration curve by using the formulae LOD=3Sa/b and 
LOQ=10Sa/b respectively and found to be 0.0261 and 0.0869 µg/mL.
Accuracy
Accuracy, percent of recovery was evaluated by using standard addition 
method at 80%, 100% and 120% concentration levels with respect to 
target concentration, and each solution was injected into column in 
triplicate, chromatograms were recorded and percent of recovery was 
calculated by from mean peak area of standard and spiked level. The 
results of accuracy were presented in Table 4.
Ruggedness
The ruggedness of an analytical method was demonstrated in terms 
of intraday precision and inter day precision. Chromatograms were 
obtained for six working standard solutions of concentration 5 µg/mL 
under the optimized conditions on day-1, and the %RSD was calculated 
on the area of the six peaks and found to be <2.0. Similarly, about 
5 µg/mL working standard solution was prepared 6 times from the 
standard stock solution on day-2, and the chromatograms were 
obtained under the optimized conditions, and the %RSD was calculated 
on area of the six peaks and found to be <2.0 and results were shown 
in Table 5.
Table 3: Linearity studies and regression analysis











Table 4: Results of accuracy of the proposed method
Spike 
level %




80 50 40 89.541 2633796 99.49
100 50 50 99.56 3294504 99.56
120 50 60 110.649 3994385 100.59
*Mean of three determinations




RT Area RT Area
1 2.924 3305808 2.925 3285556
2 2.927 3265045 2.922 3285345
3 2.923 3282897 2.926 3283325
4 2.928 3282585 2.923 3284478
5 2.926 3265864 2.921 3291245
6 2.931 3283162 2.927 3287542
Mean 2.927 3280894 2.924 3286249
SD 0.0029 14898.419 0.0024 2814.802
%RSD 0.098 0.454 0.081 0.086
RT: Reverse transcription, RSD: Relative standard deviation, SD: Standard 
deviation
Robustness
In the present investigation, the study of robustness was carried out by 
evaluating system suitable parameters under the different flow rates 
(0.6 ml/minute and 1.0 ml/minute) and temperatures at 30±2°C, and 
the results were presented in Table 6.
Degradation studies
A study of forced degradation was carried out to examine the 
stability of the drug under different degradation conditions such as 
0.1 N HCl, 0.1 N NaOH, 1.0% H2O2, exposure to heat and photo light. 
Chromatograms were recorded for each degradation condition, peak 
area of each of the chromatogram was determined, and percent of 
degradation was calculated. From the studies, it was evident that the 
Fig. 5: Chromatogram of ketorolac in acid degradation studies
Fig. 6: Chromatogram of ketorolac in base degradation studies
Fig. 7: Chromatogram of ketorolac in peroxide degradation studies
Table 6: Results of study of robustness
Serial 
no





1 Ketorolac 3.006 3412169 330848 100.00 1.14 3805
Flow rate-2
2 Ketorolac 2.511 2923251 312909 100.00 1.12 3645
Temp-1
3 Ketorolac 3.304 3444583 316010 100.00 1.15 3873
Temp-2
4 Ketorolac 2.956 3155612 313422 100.00 1.15 3856
RT: Reverse transcription
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drug was found to be stable, and the percent of degradation was found 
to be 3.58-6.62%. The results were presented in Table 7 and respective 
chromatograms were presented from Figs. 5-9.
Analysis of formulations
Preparation of sample solution: An average weight of ten tablets 
(toradol 10 mg) was calculated and made them into a fine powder. An 
amount of fine powder equivalent to 50 mg of standard ketorolac was 
weighed and transferred into a cleaned 100 mL volumetric flask and 
dissolved in 50 mL of diluent, sonicated for 10 minutes and diluted up 
to the mark and filtered the solution. Then about 1.0 mL of the above 
solution was transferred into a 100 mL volumetric flask and diluted up 
to the mark. The triplicate chromatograms of standard and sample were 
taken under the similar chromatographic conditions, and the percent of 
assay was determined, results were reported in Table 8.
CONCLUSIONS
A simple isocratic RP-HPLC method was developed for the determination 
of ketorolac in pure and pharmaceutical formulations. The proposed 
method was found to be simple, precise, accurate, robust and rugged. 
Therefore, the method can be used for routine analysis in quality control.
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